Hoque AM - Search Results

1

Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer.

Patt YZ, Hassan MM, Lozano RD, Waugh KA, Hoque AM, Frome AI, Lahoti S, Ellis L, Vauthey JN, Curley SA, Schnirer II, Raijman I. Patt YZ, et al. Among authors: hoque am. Clin Cancer Res. 2001 Nov;7(11):3375-80. Clin Cancer Res. 2001. PMID: 11705850 Clinical Trial.

2

Phase II study of paclitaxel therapy for unresectable biliary tree carcinomas.

Jones DV Jr, Lozano R, Hoque A, Markowitz A, Patt YZ. Jones DV Jr, et al. J Clin Oncol. 1996 Aug;14(8):2306-10. doi: 10.1200/JCO.1996.14.8.2306. J Clin Oncol. 1996. PMID: 8708721 Clinical Trial.

3

Phase II trial of intravenous flourouracil and subcutaneous interferon alfa-2b for biliary tract cancer.

Patt YZ, Jones DV Jr, Hoque A, Lozano R, Markowitz A, Raijman I, Lynch P, Charnsangavej C. Patt YZ, et al. J Clin Oncol. 1996 Aug;14(8):2311-5. doi: 10.1200/JCO.1996.14.8.2311. J Clin Oncol. 1996. PMID: 8708722 Clinical Trial.

4

Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin.

Patt YZ, Hoque A, Lozano R, Pozdur R, Chase J, Carrasco H, Chuang V, Delpassand ES, Ellis L, Curley S, Roh M, Jones DV Jr. Patt YZ, et al. J Clin Oncol. 1997 Apr;15(4):1432-8. doi: 10.1200/JCO.1997.15.4.1432. J Clin Oncol. 1997. PMID: 9193336 Clinical Trial.

5

Durable clinical and pathologic response of hepatocellular carcinoma to systemic and hepatic arterial administration of platinol, recombinant interferon alpha 2B, doxorubicin, and 5-fluorouracil: a communication.

Patt YZ, Hoque A, Roh M, Ellis L, Lozano R, Carrasco CH, Charnsangavej C, Cleary K. Patt YZ, et al. Am J Clin Oncol. 1999 Apr;22(2):209-13. doi: 10.1097/00000421-199904000-00024. Am J Clin Oncol. 1999. PMID: 10199464

6

Does aflatoxin B1 play a role in the etiology of hepatocellular carcinoma in the United States?

Hoque A, Patt YZ, Yoffe B, Groopman JD, Greenblatt MS, Zhang YJ, Santella RM. Hoque A, et al. Nutr Cancer. 1999;35(1):27-33. doi: 10.1207/S1532791427-33. Nutr Cancer. 1999. PMID: 10624703

7

A phase I evaluation of chronotropic delivery of floxuridine by hepatic arterial infusion in patients with metastatic colorectal cancer.

Jones D, Chase J, Roh M, Hohn D, Curley S, Smith R, Hoque A, Patt Y. Jones D, et al. Oncol Rep. 1996 Mar;3(2):391-5. Oncol Rep. 1996. PMID: 21594380

8

Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasia.

Singletary SE, Atkinson EN, Hoque A, Sneige N, Sahin AA, Fritsche HA Jr, Lotan R, Lu T, Hittelman WN, Bevers TB, Stelling CB, Lippman SM. Singletary SE, et al. Clin Cancer Res. 2002 Sep;8(9):2835-42. Clin Cancer Res. 2002. PMID: 12231524 Clinical Trial.

9

Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.

Wang L, Hoque A, Luo RZ, Yuan J, Lu Z, Nishimoto A, Liu J, Sahin AA, Lippman SM, Bast RC Jr, Yu Y. Wang L, et al. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3660-6. Clin Cancer Res. 2003. PMID: 14506155

10

Her-2/neu gene amplification in ductal carcinoma in situ of the breast.

Hoque A, Sneige N, Sahin AA, Menter DG, Bacus JW, Hortobagyi GN, Lippman SM. Hoque A, et al. Cancer Epidemiol Biomarkers Prev. 2002 Jun;11(6):587-90. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12050101

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters